Literature DB >> 18084690

Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

A M Delany1, D J McMahon, J S Powell, D A Greenberg, E S Kurland.   

Abstract

UNLABELLED: Animal models suggest a role for osteonectin/SPARC in determination of bone mass. We found haplotypes consisting of three single nucleotide polymorphisms (SNPs) in the 3' untranslated region (UTR) of the osteonectin gene are associated with bone density in Caucasian men with idiopathic osteoporosis.
INTRODUCTION: Osteonectin is a matricellular protein regulating matrix assembly, osteoblast differentiation, and survival. Animal studies indicate that osteonectin is essential for normal bone mass. The 3' UTR is a regulatory region controlling mRNA stability, trafficking, and translation, and we determined whether osteonectin 3' UTR haplotypes could be associated with bone mass and/or idiopathic osteoporosis.
METHODS: Single strand conformation polymorphism and allele-specific PCR analysis were used to assess alleles at osteonectin cDNA bases 1046, 1599, and 1970, using genomic DNA from middle-aged Caucasian men with idiopathic, low turnover osteoporosis (n = 56) and matched controls (n = 59). Bone density was measured by DXA at spine, hip and radius. Allele and haplotype frequencies were analyzed by Chi square analysis and Fisher's exact test.
RESULTS: Five common osteonectin 3' UTR haplotypes were identified. The frequency of one haplotype (1046C-1599C-1970T) was higher in controls compared with patients, and this haplotype was also associated with higher bone densities at multiple sites in patients. In contrast, a second haplotype (1046C-1599G-1970T) was associated with lower bone densities in patients at multiple sites.
CONCLUSIONS: Osteonectin regulates skeletal remodeling and bone mass in animals, and haplotypes in the 3' UTR of this gene are associated with bone density in Caucasian men with idiopathic osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084690      PMCID: PMC2888145          DOI: 10.1007/s00198-007-0523-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

Review 1.  When the message goes awry: disease-producing mutations that influence mRNA content and performance.

Authors:  J T Mendell; H C Dietz
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

Review 2.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

Authors:  A D Bradshaw; E H Sage
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture.

Authors:  S F Evans; M W J Davie
Journal:  Calcif Tissue Int       Date:  2001-12-21       Impact factor: 4.333

4.  Osteopenia and decreased bone formation in osteonectin-deficient mice.

Authors:  A M Delany; M Amling; M Priemel; C Howe; R Baron; E Canalis
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.

Authors:  Xiaodong Zhou; Filemon K Tan; John D Reveille; Debra Wallis; Dianna M Milewicz; Chul Ahn; Andrew Wang; Frank C Arnett
Journal:  Arthritis Rheum       Date:  2002-11

Review 6.  The genetics of osteoporosis: 'complexities and difficulties'.

Authors:  Y Giguère; F Rousseau
Journal:  Clin Genet       Date:  2000-03       Impact factor: 4.438

Review 7.  Role of genetic factors in the pathogenesis of osteoporosis.

Authors:  T L Stewart; S H Ralston
Journal:  J Endocrinol       Date:  2000-08       Impact factor: 4.286

8.  Osteonectin content in human osteogenesis imperfecta bone shows a range similar to that of two bovine models of OI.

Authors:  L W Fisher; M A Drum; P G Robey; K M Conn; J D Termine
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

9.  Perturbed sex steroid status in men with idiopathic osteoporosis and their sons.

Authors:  I Van Pottelbergh; S Goemaere; H Zmierczak; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

10.  Osteonectin-null mutation compromises osteoblast formation, maturation, and survival.

Authors:  Anne M Delany; Ivo Kalajzic; Amy D Bradshaw; E Helene Sage; Ernesto Canalis
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

View more
  23 in total

Review 1.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

Review 2.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

4.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

5.  A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433.

Authors:  Neha S Dole; Kristina Kapinas; Catherine B Kessler; Siu-Pok Yee; Douglas J Adams; Renata C Pereira; Anne M Delany
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 6.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

Review 7.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

Review 8.  Regulation of Bone Metabolism by microRNAs.

Authors:  Hanna Taipaleenmäki
Journal:  Curr Osteoporos Rep       Date:  2018-02       Impact factor: 5.096

9.  Evaluation of SPARC as a candidate gene of juvenile-onset primary open-angle glaucoma by mutation and copy number analyses.

Authors:  Li Jia Chen; Pancy O S Tam; Clement C Y Tham; Xiao Ying Liang; Sylvia W Y Chiang; Oscar Canlas; Robert Ritch; Douglas J Rhee; Chi Pui Pang
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

10.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.